Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (341)	12/12/1999 12:01:00 AM
From: RWReeves	Read Replies (2) \| Respond to of 3557

Miljenko, don't be upset by what I said. I recognize your track record; you'd asked for other POV's and I am adding information for you to consider or reject. You probably studied REGN far better than I who has only been casually interested since their clinical disappointment. As to doing my homework, well, yes I do my "homework" every day on the job and know these costs pretty well. I don't want to say much more than that. I think it is a shame so many companies spend so much money on plant with the expectation of PI/II success. And yes it's great that MRK is paying for it. You can find details on similar deals at Recap. I'd be surprised to see REGN go up 400% on Monday, but no I wouldn't buy it under those circumstances. RWR